title: A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.
abstract: OBJECTIVE
  To create a risk score for death from cardiovascular disease that can be easily used.
  
  
  METHODS
  Data from eight randomised controlled trials of antihypertensive treatment.
  
  
  METHODS
  Europe and North America.
  
  
  METHODS
  47 088 men and women from trials that had differing age ranges and differing eligibility criteria for blood pressure. MAIN OTUCOME MEASURE: 1639 deaths from cardiovascular causes during a mean 5.2 years of follow up.
  
  
  RESULTS
  Baseline factors were related to risk of death from cardiovascular disease using a multivariate Cox model, adjusting for trial and treatment group (active versus control). A risk score was developed from 11 factors: age, sex, systolic blood pressure, serum total cholesterol concentration, height, serum creatinine concentration, cigarette smoking, diabetes, left ventricular hypertrophy, history of stroke, and history of myocardial infarction. The risk score is an integer, with points added for each factor according to its association with risk. Smoking contributed more in women and in younger age groups. In women total cholesterol concentration mattered less than in men, whereas diabetes had more of an effect. Antihypertensive treatment reduced the score. The five year risk of death from cardiovascular disease for scores of 10, 20, 30, 40, 50, and 60 was 0.1%, 0.3%, 0.8%, 2.3%, 6.1%, and 15.6%, respectively. Age and sex distributions of the score from the two UK trials enabled individual risk assessment to be age and sex specific. Risk prediction models are also presented for fatal coronary heart disease, fatal stroke, and all cause mortality.
  
  
  CONCLUSIONS
  The risk score is an objective aid to assessing an individual's risk of cardiovascular disease, including stroke and coronary heart disease. It is useful for physicians when determining an individual's need for antihypertensive treatment and other management strategies for cardiovascular risk.
authors.affiliation: Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT. stuart.pocock@lshtm.ac.uk
authors.forename: S J
authors.initials: SJ
authors.lastname: Pocock
authors.forename: V
authors.initials: V
authors.lastname: McCormack
authors.forename: F
authors.initials: F
authors.lastname: Gueyffier
authors.forename: F
authors.initials: F
authors.lastname: Boutitie
authors.forename: R H
authors.initials: RH
authors.lastname: Fagard
authors.forename: J P
authors.initials: JP
authors.lastname: Boissel
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality* / Q000517:prevention & control; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000401:mortality / Q000517:prevention & control; D015996:Survival Rate
chemical_list: D000959:Antihypertensive Agents